Work

Phase-I/II Study of Bortezomib in Combination with Carboplatin and Bevacizumab as First-Line Therapy in Patients With Advanced Non–Small-Cell Lung Cancer

Year: 2012

Type: article

Study design: Clinical Trial

Source: Journal of Thoracic Oncology

DOI: 10.1097/jto.0b013e31824de2fa

Authors: Bilal Piperdi, William V. Walsh, Kendra Bradley, Zheng Zhou, Venu Bathini, Meredith Hanrahan-Boshes, Lloyd Hutchinson, Roman Perez-Soler

Institutions: Albert Einstein College of Medicine, Montefiore Medical Center, Montefiore Einstein Comprehensive Cancer Center, University of Massachusetts Chan Medical School, UMass Memorial Medical Center

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: National Institutes of Health, Takeda Oncology, National Cancer Institute

Awards: G1394397566, Paul Calabresi Career Development Award for Clinical Oncology (K12)

OpenAlex ID: W1999260523

FWCI: 2.32

Cites: 36

Cited by: 32

Related to: 10